Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
KPRX Kiora Pharmaceuticals
3.570-0.100-2.72%
Close
01/27 16:00 ET
3.5700.0000.00%
Post Mkt Price 01/27 16:07 ET
High
3.820
Open
3.820
Turnover
193.56K
Low
3.485
Pre Close
3.670
Volume
53.88K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) Sees Significant Decline in Short Interest
Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX – Get Rating) saw a significant drop in short interest in December. As of December 30th, there was short interest totalling 15,400 shares, a drop of 34.2% fr
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersLipella Pharmaceuticals (NASDAQ:LIPO) stock moved upwards by 110.0% to $6.53 during Wednesday's pre-market session. The market value of their outstanding shares is at $37.5 million. Biora Thera
Kiora Pharmaceuticals Highlights Anticipated Clinical and Corporate Milestones for 2023; Webcast Now Available on Company Website
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Swvl Holdings Corp. (NASDAQ:SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.Spruce Biosciences, Inc. (NASDAQ:SPRB) shares jumped 100.8% to
12 Health Care Stocks Moving In Friday's Intraday Session
GainersSpruce Biosciences (NASDAQ:SPRB) stock increased by 85.6% to $2.32 during Friday's regular session. The current volume of 54.1 million shares is 44894.7% of Spruce Biosciences's average full-da
KALA, KC and CTMX Are Among Pre Market Gainers
Why Geron Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Gainers Vyant Bio, Inc. (NASDAQ:VYNT) shares rose 110.4% to $1.62 in pre-market trading after the company said it has engaged LifeSci Capital as its advisor to explore strategic alternatives.Humanigen
H.C. Wainwright Sticks to Its Buy Rating for Kiora Pharmaceuticals (KPRX)
Kiora Pharmaceuticals Completes Enrollment in Phase 2 Study, Says Ladenburg
Kiora Pharmaceuticals Shares Resume Trade Shares Spike Higher, Stock Now Up 8%
Kiora Pharmaceuticals Shares Resume Trade Shares Spike Higher, Stock Now Up 8%
Company Overview
More
Kiora Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.
CEO： Mr. Brian M. Strem
Market： NASDAQ
Listing Date： 02/13/2015
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet